Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura

Journal of Thrombosis and Thrombolysis

Volumn 35, Issue 2, 2013, Pages 228-233

  Celik, Muhittin ^a   Bulbul, Ali ^a   Aydogan, Gönül ^b   Tugcu, Deniz ^b   Can, Emrah ^a   Uslu, Sinan ^a   Dursun, Mesut ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Kanuni Sultan Suleyman Delivery and Children Hospital Education and Research Hospital   (Turkey)

Author keywords

Anti D immunoglobulin; Cost; Immune thrombocytopenic purpura; Intravenous immunoglobulin; Methylprednisolone

Indexed keywords

IMMUNOGLOBULIN G; METHYLPREDNISOLONE; RHESUS D ANTIBODY;

ANEMIA; ARTICLE; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCREASED APPETITE; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT OUTCOME; WEIGHT GAIN;

CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RHO(D) IMMUNE GLOBULIN;

EID: 84877028066     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0801-z     Document Type: Article

References (30)

1. Wilson DB (2003) Acquired platelet defects. In: Nathan DG, Oski SH, Ginsberg D, Look AT (eds) Nathan and Oski's hematology of infancy and childhood, 6th edn. Saunders, Philadelphia, pp 1597-1609
2. Kiefel V, Santoso S, Kaufmann E et al (1991) Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 79:256-262
3. Imbach PA, Kühne T, Hollander G (1997) Immunologic aspects in the pathogenesis and treatment of immune thrombocytopenic purpura in children. Curr Opin Pediatr 9:35-40
4. Sutor AH, Harmas A, Kaufmehl K (2001) Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 27:253-267
5. Aygun B (2005) Disorders of platelets. In: Lanzkowsky P (ed) Manual of pediatric hematology and oncology, 4th edn. Elsevier, San Diego, pp 250-294
6. Psaila B, Bussel JB (2007) Immune thrombocytopenic purpura. Hematol Oncol Clin North Am 21:743-759
7. Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386-2393
8. George JN, Woolf SH, Raskop GE et al (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3-40
9. Shahgholi E, Vosough P, Sotoudeh K et al (2008) Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Indian J Pediatr 75:1231-1235
10. Trebo MM, Frey E, Gadner H et al (2010) Subcutaneous anti-D globulin application is a safe treatment option of immune thrombocytopenia in children. Ann Hematol 89:415-418
11. Bussel JB, Graziano JN, Kimberly RP et al (1991) Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood 77:1884-1893
12. Provan D, Stasi R, Newland AC, Victor S et al (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115:168-186
13. Gaines AR (2005) Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 106:1532-1537
14. Neunert C, Lim W, Crowther M et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:4190-4207
15. Imbach P, Barandum S, d'Appuzzo V et al (1981) High-dose gammaglobulin for idiopathic thrombocytopenic purpura in children. Lancet 1:1228-1231
16. Salama A, Kiefel V, Amberg R, Mueller-Eckhart CD (1984) Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies [anti-Rho(d)]. Ann Hematol 49:29-35
17. Lazarus AH, Fredman J, Semple JW (1998) Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action. Transfus Sci 19:289-294
18. Lazarus AH, Crow AR (2003) Mechanism of action of IVIG and anti-D in ITP. Transfus Sci 28:249-255
19. Tarantino MD, Renee MM, Lucille F et al (1999) Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr 134:21-26
20. Moser AM, Shalev H, Kapelushnik J (2002) Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 19:407-411
21. Naithani R, Kumar R, Mahapatra M et al (2010) Efficacy and safety of anti-D for immune thrombocytopenic purpura in children. Indian Pediatr 47:517-519
22. Papagianni A, Economou M, Tragiannidis A et al (2011) Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia. J Pediatr Hematol Oncol 33:265-269
23. Newman GC, Novoa MV, Fodero EM et al (2001) A dose of 75 μg/kg/d anti-D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d anti-D in adults with immune thrombocytopenic purpura. Br J Haematol 112:1076-1078
24. Son DW, Jeon IS, Yang SW et al (2008) A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children. J Pediatr Hematol Oncol 30:598-601
25. Borst F, Keuning JJ, van Hulsteijn H et al (2004) High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. Ann Hematol 83:764-768
26. Wali YA, Al Lamki Z, Shah W, Zacharia M, Hassan A (2002) Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 19:329-335
27. Kühne T, Buchanan GR, Zimmerman S et al (2003) A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 143:605-608
28. Muller BU, Imbach P (1989) Prevention of chronic ITP? Blood 59:109-110
29. Sandler SG, Novak SC, Roland B (2000) The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin. Am J Hematol 63:156-158
30. Kumar M, Vik TA, Johnson CS et al (2005) Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura. Am J Hematol 78:181-187